Literature DB >> 22232290

Dissemination of the fosfomycin resistance gene fosA3 with CTX-M β-lactamase genes and rmtB carried on IncFII plasmids among Escherichia coli isolates from pets in China.

Jianxia Hou1, Xianhui Huang, Yuting Deng, Liangying He, Tong Yang, Zhenling Zeng, Zhangliu Chen, Jian-Hua Liu.   

Abstract

The presence and characterization of plasmid-mediated fosfomycin resistance determinants among Escherichia coli isolates collected from pets in China between 2006 and 2010 were investigated. Twenty-nine isolates (9.0%) were positive for fosA3, and all of them were CTX-M producers. The fosA3 genes were flanked by IS26 and were localized on F2:A-:B- plasmids or on very similar F33:A-:B- plasmids carrying both bla(CTX-M-65) and rmtB. These findings indicate that the fosA3 gene may be coselected by antimicrobials other than fosfomycin.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22232290      PMCID： PMC3318358          DOI： 10.1128/AAC.05104-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  26 in total

1.  Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes.

Authors:  Jun-ichi Wachino; Kunikazu Yamane; Satowa Suzuki; Kouji Kimura; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2010-04-19       Impact factor: 5.191

2.  Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin.

Authors:  Matthew E Falagas; Sofia Maraki; Drosos E Karageorgopoulos; Antonia C Kastoris; Emmanuel Mavromanolakis; George Samonis
Journal:  Int J Antimicrob Agents       Date:  2010-03       Impact factor: 5.283

3.  In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin.

Authors:  Andrea Endimiani; Gopi Patel; Kristine M Hujer; Mahesh Swaminathan; Federico Perez; Louis B Rice; Michael R Jacobs; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2009-11-09       Impact factor: 5.191

4.  Fosfomycin susceptibility among extended-spectrum-beta-lactamase-producing Escherichia coli in Nottingham, UK.

Authors:  R J Chislett; G White; T Hills; D P J Turner
Journal:  J Antimicrob Chemother       Date:  2010-02-24       Impact factor: 5.790

5.  Complete nucleotide sequence of the fosfomycin resistance transposon Tn2921.

Authors:  Asunción Seoane; Felix J Sangari; Juan M García Lobo
Journal:  Int J Antimicrob Agents       Date:  2010-04       Impact factor: 5.283

6.  Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials.

Authors:  George Samonis; Sofia Maraki; Petros I Rafailidis; Anastasios Kapaskelis; Antonia C Kastoris; Matthew E Falagas
Journal:  Future Microbiol       Date:  2010-06       Impact factor: 3.165

Review 7.  Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review.

Authors:  Matthew E Falagas; Antonia C Kastoris; Anastasios M Kapaskelis; Drosos E Karageorgopoulos
Journal:  Lancet Infect Dis       Date:  2010-01       Impact factor: 25.071

8.  Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli.

Authors:  Sho Takahata; Takashi Ida; Toru Hiraishi; Shiro Sakakibara; Kazunori Maebashi; Shinichi Terada; Tetsuro Muratani; Tetsuro Matsumoto; Chikara Nakahama; Kazunori Tomono
Journal:  Int J Antimicrob Agents       Date:  2010-01-13       Impact factor: 5.283

Review 9.  Fosfomycin: use beyond urinary tract and gastrointestinal infections.

Authors:  Matthew E Falagas; Konstantina P Giannopoulou; George N Kokolakis; Petros I Rafailidis
Journal:  Clin Infect Dis       Date:  2008-04-01       Impact factor: 9.079

10.  CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.

Authors:  Jesús Oteo; Beatriz Orden; Verónica Bautista; Oscar Cuevas; Margarita Arroyo; Rocío Martínez-Ruiz; María Pérez-Vázquez; Marta Alcaraz; Silvia García-Cobos; José Campos
Journal:  J Antimicrob Chemother       Date:  2009-08-11       Impact factor: 5.790
View more
  48 in total

1.  First report of a clinical, multidrug-resistant Enterobacteriaceae isolate coharboring fosfomycin resistance gene fosA3 and carbapenemase gene blaKPC-2 on the same transposon, Tn1721.

Authors:  Gang Li; Ying Zhang; Dexi Bi; Pinghua Shen; Fuqi Ai; Hong Liu; Yueru Tian; Yiming Ma; Bei Wang; Kumar Rajakumar; Hong-Yu Ou; Xiaofei Jiang
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Practical agar-based disk potentiation test for detection of fosfomycin-nonsusceptible Escherichia coli clinical isolates producing glutathione S-transferases.

Authors:  Genki Nakamura; Jun-Ichi Wachino; Natsumi Sato; Kouji Kimura; Keiko Yamada; Wanchun Jin; Keigo Shibayama; Tetsuya Yagi; Kumiko Kawamura; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2014-06-20       Impact factor: 5.948

3.  Coproduction of MCR-1 and NDM-1 by Colistin-Resistant Escherichia coli Isolated from a Healthy Individual.

Authors:  Lan-Lan Zhong; Yan-Fen Zhang; Yohei Doi; Xi Huang; Xue-Fei Zhang; Kun-Jiao Zeng; Cong Shen; Sandip Patil; Yong Xing; Yutian Zou; Guo-Bao Tian
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

4.  Coexistence of CTX-M-2, CTX-M-55, CMY-2, FosA3, and QnrB19 in Extraintestinal Pathogenic Escherichia coli from Poultry in Brazil.

Authors:  Marcos P V Cunha; Nilton Lincopan; Louise Cerdeira; Fernanda Esposito; Milena Dropa; Leticia S Franco; Andrea M Moreno; Terezinha Knöbl
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 5.  Fosfomycin: Resurgence of an old companion.

Authors:  Sangeeta Sastry; Yohei Doi
Journal:  J Infect Chemother       Date:  2016-02-28       Impact factor: 2.211

6.  Evaluation of disk potentiation test using kirby-bauer disks containing high-dosage fosfomycin and glucose-6-phosphate to detect production of glutathione S-transferase responsible for fosfomycin resistance.

Authors:  Jun-ichi Wachino; Kouji Kimura; Keiko Yamada; Wanchun Jin; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2014-08-13       Impact factor: 5.948

7.  Emergence of Colistin Resistance Gene mcr-1 in Cronobacter sakazakii Producing NDM-9 and in Escherichia coli from the Same Animal.

Authors:  Bao-Tao Liu; Feng-Jing Song; Ming Zou; Zhi-Hui Hao; Hu Shan
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

8.  First Detection of a Fosfomycin Resistance Gene, fosA7, in Salmonella enterica Serovar Heidelberg Isolated from Broiler Chickens.

Authors:  Muhammad A Rehman; Xianhua Yin; Marissa G Persaud-Lachhman; Moussa S Diarra
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

9.  Characterization of IncI1 sequence type 71 epidemic plasmid lineage responsible for the recent dissemination of CTX-M-65 extended-spectrum β-lactamase in the Bolivian Chaco region.

Authors:  Eleonora Riccobono; Vincenzo Di Pilato; Tiziana Di Maggio; Carmen Revollo; Alessandro Bartoloni; Lucia Pallecchi; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2015-06-22       Impact factor: 5.191

10.  Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives.

Authors:  Sylvie Garneau-Tsodikova; Kristin J Labby
Journal:  Medchemcomm       Date:  2015-09-21       Impact factor: 3.597
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.